05:58 AM EDT, 07/10/2026 (MT Newswires) -- Berenberg raised its price target for Sartorius AG (SRT.F, SRT3.F) ahead of the company's second-quarter results on July 23, reflecting "higher confidence" in its long-term outlook on the back of end-market improvements. The research firm said Friday it expects the life science equipment and technology supplier's group revenue to grow 7.9% in the second quarter, above the 7.5% consensus, boosted by its bioprocessing division amid expected gains in consumables and equipment. "We are more focused on Q2 growth, as well as the commentary it provides regarding current trading and forward-looking indicators. Sartorius faced a challenging period following COVID-19 when it had poor demand visibility. Therefore, while we ultimately expect the company to deliver growth at the high end of the guided range, management could take a cautious approach when setting guidance," Berenberg said. Against this backdrop, the stock's price target was raised to 270 euros from 250 euros, with an unchanged buy rating.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.